Treatment-Resistant Depression in Jacksonville, FL: When Standard Care Falls Short

Woman sitting on pier after receiving treatment resistant depression care in jacksonville fl

Treatment-resistant depression is typically used to describe depression that has not improved adequately after multiple appropriate antidepressant trials. For patients in Jacksonville and across Northeast Florida who have cycled through SSRIs, SNRIs, and other treatment strategies without meaningful relief, the question becomes what evidence-based options may be appropriate next.

At Altitude Health, we work with patients who have reached that point, and we want to be direct about what a more thorough evaluation can involve.

What “Treatment-Resistant” Actually Means

The term treatment-resistant depression, or TRD, is sometimes used loosely. In clinical practice, it generally refers to major depression that has not responded adequately to at least two antidepressant trials that were appropriate in dose, duration, and adherence.

A full treatment history matters. Someone who has tried two medications may need a different evaluation than someone who has also tried medication augmentation, structured psychotherapy, or interventional treatment. Both experiences are important, but the next step should reflect the complete clinical picture—not simply the number of medications on a list.

Why Antidepressants May Not Be Enough

Standard antidepressants work through several pathways involving serotonin, norepinephrine, and dopamine. These medications can be effective for many people, but depression is not a single condition with one biological cause.

The STAR*D study found that remission became less common across later treatment steps. This does not mean a patient has failed treatment or that recovery is out of reach. It means that when standard approaches have not provided adequate relief, it may be time to reassess the diagnosis, prior treatment trials, co-occurring conditions, therapy history, and available options.

How Ketamine Works Differently

Ketamine infusion therapy works through a different pathway than conventional antidepressants. It acts primarily on the glutamate system through NMDA receptors rather than focusing primarily on monoamines.

Clinical trials and systematic reviews support ketamine’s potential antidepressant effects for some adults with treatment-resistant depression. Some patients notice changes quickly, while others may not respond or may need a broader treatment plan to maintain improvement.

At Altitude Health, we offer ketamine infusion therapy for patients who meet clinical criteria and have completed a thorough evaluation. Ketamine use for psychiatric conditions is off-label, and it is not appropriate for everyone. We review psychiatric history, current medications, medical factors, treatment goals, and safety considerations before making a recommendation.

SPRAVATO®: An FDA-Approved Option for TRD

SPRAVATO® for treatment-resistant depression is an FDA-approved esketamine nasal spray for adults with TRD. It is administered in a certified healthcare setting, where patients are monitored after each treatment.

SPRAVATO® differs from IV ketamine in its route of administration, regulatory status, treatment process, and coverage considerations. Eligibility depends on your diagnosis, prior medication history, current symptoms, medical history, and the clinical judgment of your provider.

At Altitude Health, we discuss SPRAVATO® with patients whose treatment history and current needs suggest it may be a reasonable option to consider.

TMS: A Non-Medication Option With Strong Evidence

TMS therapy for depression is an FDA-cleared, noninvasive treatment for major depressive disorder. It uses targeted magnetic pulses to stimulate areas of the brain involved in mood regulation.

TMS can be an option for patients who have not responded adequately to antidepressants, who have experienced difficult medication side effects, or who would prefer to discuss a non-medication treatment approach. Treatment typically involves a series of outpatient sessions over several weeks, with the schedule tailored to the treatment protocol and individual needs.

We discuss TMS as part of a broader evaluation. It is not the right fit for every patient, but it can be a meaningful option for people whose depression has persisted despite standard care.

Addressing Two Barriers We Hear Consistently

One of the most common concerns we hear from patients with TRD is the cost and insurance complexity of advanced treatment options. Coverage can vary significantly by treatment and insurance plan. We believe patients deserve clear information about the practical side of care before making a decision.

A second barrier is exhaustion. Many patients with TRD have been through years of medication changes, appointments, and disappointment. It is understandable to feel skeptical about trying something new.

We do not offer unfounded optimism. We offer an honest assessment of what has been tried, what may still be worth considering, and what the evidence can and cannot tell us about potential outcomes. Results vary by individual.

Putting Together a TRD Treatment Plan

At Altitude Health in Jacksonville, our approach begins with a thorough intake evaluation. We review medication trials, treatment response, augmentation history, therapy experience, current symptoms, and prior interventional care.

A treatment plan may include medication management, talk therapy integrated with psychiatric treatment, ketamine infusion therapy, SPRAVATO®, TMS, or another clinically appropriate option.

We do not apply a single protocol to every patient with TRD. Depression that has not responded to standard care deserves an individualized plan built around the full history—not assumptions about what should come next.

Frequently Asked Questions

How many antidepressants do I need to have tried before I qualify for TRD treatment?

TRD is commonly defined as inadequate response to at least two appropriate antidepressant trials. Specific eligibility requirements can vary by treatment and insurance plan. Bring your medication list and approximate treatment dates to your consultation so we can review your history carefully.

Is SPRAVATO® the same as ketamine?

No. SPRAVATO® is esketamine nasal spray, while ketamine infusion therapy is administered intravenously. They are related medications but differ in route of administration, treatment process, regulatory status, and clinical considerations.

How quickly does ketamine work for treatment-resistant depression?

Some patients report changes in depressive symptoms within hours or days, but response and duration of benefit vary. Ketamine is not a guaranteed or permanent solution, and treatment decisions should follow a thorough clinical evaluation.

Does TMS work for patients who have not responded to antidepressants?

TMS is FDA-cleared for major depressive disorder and may be considered for patients who have not achieved adequate relief with antidepressants. We evaluate whether it fits the individual’s symptoms, treatment history, medical considerations, and goals.

Can I combine ketamine infusions with my current medications?

That depends on your medication list and medical history. Some medications may require closer evaluation before treatment. Never stop or adjust psychiatric medication without guidance from your prescribing provider.

Key Takeaways

  • Treatment-resistant depression usually involves inadequate response to at least two appropriate antidepressant trials.
  • A full treatment-history review is important before concluding that no options remain.
  • Ketamine infusion therapy is off-label for psychiatric conditions and may be considered for some patients with TRD.
  • SPRAVATO® is FDA-approved for adults with treatment-resistant depression.
  • TMS is FDA-cleared for major depressive disorder and may be an option for some people who have not improved with antidepressants.
  • Results vary by individual, and the right next step depends on a complete clinical evaluation.

Conclusion

Treatment-resistant depression is not a life sentence, but it may require a different kind of evaluation than standard outpatient medication management alone.

At Altitude Health in Jacksonville, we review each patient’s full treatment history before recommending a specific approach. Call 904-877-8275 or schedule a consultation to discuss your options with our team.

Works Cited

McIntyre, R. S., Alsuwaidan, M., Baune, B. T., et al. (2023). Treatment-resistant depression: Definition, prevalence, detection, management, and investigational interventions. World Psychiatry, 22(3), 394–412. https://doi.org/10.1002/wps.21120

Rakesh, G., Cordero, P., Khanal, R., Himelhoch, S. S., & Rush, C. R. (2024). Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and meta-analysis. Journal of Affective Disorders, 358, 432–439. https://doi.org/10.1016/j.jad.2024.05.037

Rush, A. J., Trivedi, M. H., Wisniewski, S. R., et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163(11), 1905–1917. https://doi.org/10.1176/ajp.2006.163.11.1905

Seshadri, A., Prokop, L. J., & Singh, B. (2024). Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for major depression: A systematic review and meta-analysis. Journal of Affective Disorders, 356, 379–384. https://doi.org/10.1016/j.jad.2024.03.137

U.S. Food and Drug Administration. (2025). SPRAVATO® (esketamine) nasal spray prescribing information.

Medical Disclaimer

The information in this blog post is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Treatment for depression and treatment-resistant depression should only be pursued under the supervision of qualified licensed providers familiar with your complete medical and psychiatric history. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, call or text 988 to reach the Suicide & Crisis Lifeline or go to your nearest emergency room.

Share Now :